← Back to headlines
Embecta CEO Bets on GLP-1 and Diversification for U.S. Reset
Embecta's CEO is focusing on GLP-1 drugs and diversification through Owen Mumford to reset the company's strategy in the U.S. market.
16 May, 16:06 — 16 May, 16:06
Sources
Showing 1 of 1 sources
